Eagle Pharmaceuticals Inc

NASDAQ:EGRX   3:59:58 PM EDT
47.77
-0.33 (-0.69%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)616.87M
Current PE109.65
Forward PE 17.5
2yr Forward PE 7.41
See more stats
Estimates Current Quarter
Revenue$51.54 Million
Adjusted EPS$0.95
See more estimates
10-Day MA$49.81
50-Day MA$52.76
200-Day MA$46.60
See more pivots

Eagle Pharmaceuticals Inc Stock, NASDAQ:EGRX

50 Tice Boulevard, Suite 315, Woodcliff Lake, New Jersey 07677-9991
United States of America
Phone: +1.201.326.5300
Number of Employees: 106

Description

Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.